Journals / MN Kardiyoloji / 2003 / Cilt: 10 - Sayı: 2

Multivessel intervention in acute myocardial infarction

Akut miyokard infarktüsünde çok damar girişimi

Pages
80–83
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the MACE rates in group I was greater than those of group II in-hospital (11.5% in group I vs 5.2% in group II; p>0.05) and at 1 month (13.1% in group I vs 10.5% in group II; p>0.05), and there was a trend toward higher MACE rates in group II than those of group I at 6 months (21% in group II vs 14.8% in group I; p>0.05), these did not reach statistical significance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The clinical benefits of multivessel procedure in addition to infarct-related artery revascularization in patients with ST-elevation myocardial infarction (MI) is not well known.
📊
Key Findings & Data:Patients were divided into two groups as group I (n=61), patients undergoing single vessel procedure, and group II (n=19), patients undergoing multivessel procedure.
💡
Conclusion & Impact:Although the MACE rates in group I was greater than those of group II in-hospital (11.5% in group I vs 5.2% in group II; p>0.05) and at 1 month (13.1% in group I vs 10.5% in group II; p>0.05), and there was a trend toward higher MACE rates in group II than those of group I at 6 months (21% in group II vs 14.8% in group I; p>0.05), these did not reach statistical significance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anjiyoplasti · balon · Miyokard enfarktüsü

Abstract

Aim: The clinical benefits of multivessel procedure in addition to infarct-related artery revascularization in patients with ST-elevation myocardial infarction (MI) is not well known. This study was planned to compare the clinical outcomes of single vessel procedure versus multivessel coronary interventions in patients with ST-elevation MI Material and Methods: Eighty patients presenting with the diagnosis of ST-elevation MI treated with primary balloon angioplasty were enrolled. Patients were divided into two groups as group I (n=61), patients undergoing single vessel procedure, and group II (n=19), patients undergoing multivessel procedure. Primary end-points of the study were determined as the major cardiac events (MACE; death, non-fatal MI, and repeat revascularization) in-hospital, at 30 days, and at 6 months. Results: There were no differences between two groups in terms of basaline demographic, clinical and angiographic data. Angiographic success was achieved in 100% in group I, and 94.8% in group II. Although the MACE rates in group I was greater than those of group II in-hospital (11.5% in group I vs 5.2% in group II; p>0.05) and at 1 month (13.1% in group I vs 10.5% in group II; p>0.05), and there was a trend toward higher MACE rates in group II than those of group I at 6 months (21% in group II vs 14.8% in group I; p>0.05), these did not reach statistical significance.

Özet

Amaç: ST segment yüksekliği olan akut miyokard infarktüslü (AMİ) hastalarda infarktla ilişkili arterin balon anjiyoplasti ile açılmasına ek olarak lezyon bulunan diğer arterlerin de aynı seansda açılmasının klinik sonuçları bilinmemektedir. Bu çalışmada ST segment yüksekliği olan AMİ'lü hastalarda infarktüs esnasında çok damar girişimi ile tek damar girişiminin klinik sonuçlarının karşılaştırılması planlandı. Gereç ve Yöntem: Çalışmaya ST segment yüksekliği olan AMİ tanısıyla primer balon anjiyoplasti yapılan toplam 80 hasta alındı Hastalar tek damara balon anjiyoplasti yapılan (grup I, n=61) ve çok damara girişim yapılanlar (grup II, n=19) olmak üzere iki gruba ayrıldılar. Çalışmanın primer sonlanım noktası hastane içi, 1. ay ve 6. ayda major kardiyak olaylar (ölüm, ölümcül olmayan miyokard infarktüsü ve yeniden revaskülarizasyon) olarak belirlendi. Bulgular: Gruplar arasında bazal demografik, klinik ve anjiyografik özellikler bakımından istatistiksel olarak anlamlı bir fark yoktu (p>0.05). Anjiyografik başarı grup I'deki hastaların %100'ünde grup II'deki hastaların %94.8'inde elde edildi. Major kardiyak olay oranı hastane içi ve 1. ayda grup I'de grup II'den daha yüksek (hastane içinde %11.5'e karşılık %5.2, p>0.05, 1. ayda, %13.1'e karşılık %10.5, p>0.05), 6. ayda ise grup II'de daha fazla olma eğilimine rağmen (%21'e karşılık %14.8'e, p>0.05), bunlar istatistiksel öneme ulaşmadı. Sonuç: ST segment yüksekliği olan AMİ'lı hastalarda çok damar girişimi etkin ve emniyetli gibi görünmektedir.

🔖

Cite This Article

ATMACA, Y., ÖZDOL, Ç., ALTIN, T., TOLUNAY, C., GEREDE, M., DANDACHİ, R., ÖZDEMİR, A., TUTAR, E., GÜLEÇ, S., KUMBASAR, D., ORAL, D. (2003). Multivessel intervention in acute myocardial infarction. MN Kardiyoloji, Cilt: 10 - Sayı: 2, 80–83. https://ajindex.com/articles/297809

References (7)

  1. Steg G, Seknadji'P. Primary PTCA: Possibly the best, often the only choice for reperfusion in acute myocardial infarction. J Thromb and Thrombolysis 1997; 4:331-6.
  2. Grines CL, Browne KF, Marco J, et al.A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328:673-9. Zilstra F, de Boer MJ, Beukema WP, et al. Mortality, reinfarction, left ventricular ejection fraction and cost following reperfusion therapies for acute myocardial infarction. Eur Heart J 1996; 17:382-7. The Gusto lib Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasmi- nogen activator for acute myocardial infarction: the Global Use of Strategies To Open occluded coronary arteries in acute coro­ nary syndromes (Gusto lib) Angioplasty substudy. N Engl J Med 1997; 336:1621-8. de Boer MJ, Ottervanger JP, van't Hof AWJ, Hoorntje JCA, Suryapranata H, Zijlstra F. Reperfusion therapy in elderly patients with acute myocardial infarction: A Randomized Comparison of Primary Angioplasty and Thrombolytic Therapy. J Am Coll Cardiol 2002; 39:1723-8.
  3. Grines CL, Westerhausen DR, Grines LL, et al. (The Air PAMI Study Group). A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The Air Primary Angioplasty in Myocardial Infarction Study. J Am Coll Cardiol 2002; 39:1713-9.
  4. Webb JG, Sanborn TA, Sleeper LA, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J 2001; 141:964-70.
  5. Ammann P, Straumann E, Naegeli B, et al. Long-term results after acute percutaneous transluminal coronary angioplasty in a- cute myocardial infarction and cardiogenic shock. Int J Cardiol 2002; 82:127-31. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335:217-25.
  6. Serruys PW, Unger F, Sousa E, et al. (The Arterial Revascularization Study Group). Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344:1117-24. van den Brand MJBM, Rensing BJWM, Morel MM, et al. The effect of completeness of revascularization on event-free survi­ val atone year in the ARTS trial. J Am Coll Cardiol 2002; 39:559-64.
  7. Kloeter UCD, Jander NG, Buser PT, Ossw